The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose ...
Narcan is the FDA-approved nasal form of naloxone for the emergency treatment of a known or suspected opioid overdose. The ...
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
Opinion: While Congress continues to discuss Alternatives to Prevent Addiction in the Nation (PAIN) Act, passing it seems ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
In addition to Narcan, sheriff's departments in at least three states have begun using another overdose reversal nasal spray ...
The number of people living with CF worldwide is now 105,000, up from 70,000 in 2012, according to estimates from US ...
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg. This nasal spray ...
The exponential rise in opioid prescriptions by pharmaceutical companies, despite awareness of their addictive nature, has ...